|
|
||||||||
B and tumor necrosis factor-
in macrophages
1 Department of Basic Pharmaceutical Sciences, Health Sciences Center, West Virginia University, Morgantown 26506; 2 Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505; and 3 Nelson Institute of Environmental Medicine, New York University, Tuxedo, New York 10016
The APO-1/Fas
ligand (FasL) and tumor necrosis factor-
(TNF-
) are two
functionally related molecules that induce apoptosis of
susceptible cells. Although the two molecules have been reported to
induce apoptosis via distinct signaling pathways, we have shown that FasL can also upregulate the expression of TNF-
, raising the
possibility that TNF-
may be involved in FasL-induced
apoptosis. Because TNF-
gene expression is under the control
of nuclear factor-
B (NF-
B), we investigated whether FasL can
induce NF-
B activation and whether such activation plays a role in
FasL-mediated cell death in macrophages. Gene transfection studies
using NF-
B-dependent reporter plasmid showed that FasL did activate
NF-
B promoter activity. Gel shift studies also revealed that FasL
mobilized the p50/p65 heterodimeric form of NF-
B. Inhibition of
NF-
B by a specific NF-
B inhibitor, caffeic acid phenylethyl
ester, or by dominant expression of the NF-
B inhibitory subunit
I
B caused an increase in FasL-induced apoptosis and a
reduction in TNF-
expression. However, neutralization of TNF-
by
specific anti-TNF-
antibody had no effect on FasL-induced
apoptosis. These results indicate that FasL-mediated cell death
in macrophages is regulated through NF-
B and is independent of
TNF-
activation, suggesting the antiapoptotic role of NF-
B
and a separate death signaling pathway mediated by FasL.
tumor necrosis factor-
receptor; caspase-activated
deoxyribonuclease
This article has been cited by other articles:
![]() |
R. J. Rasoulpour and K. Boekelheide NF-{kappa}B Is Activated in the Rat Testis Following Exposure to Mono-(2-Ethylhexyl) Phthalate Biol Reprod, February 1, 2005; 72(2): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dan, T. Kanai, T. Totsuka, R. Iiyama, M. Yamazaki, T. Sawada, T. Miyata, H. Yagita, K. Okumura, and M. Watanabe Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis Am J Physiol Gastrointest Liver Physiol, October 1, 2003; 285(4): G754 - G760. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |